Jennifer Marty has held several scientific and business positions in the Australian pharmaceutical industry, including executive positions with the biopharmaceutical company Amgen Australia. In the past 10 years she has worked independently, providing consulting services to various Australian biotechnology and pharmaceutical companies in the fields of pharmaceutical product development and commercialization and served on some federal government committees.
Jennifer became involved with DEBRA in 2007, assisting with submissions to the Australian government that led to the establishment of the EB dressing scheme. Since then she has continued to act as an advisor/mentor and joined the Board when DEBRA Australia Ltd was set up in 2012, chairing the Nurse Programs and Research Committees. From 2014 until 2022 Jennifer became the Board Chair of DEBRA Australia.
Jennifer holds a Doctoral degree in Pharmacy (Victorian College of Pharmacy/Monash University), a Graduate Diploma in Business Administration (Monash University) and a company director’s graduate diploma.